Factors Affecting Healthy Volunteers' Long-Term Participation in Clinical Trials
影响健康志愿者长期参与临床试验的因素
基本信息
- 批准号:8611663
- 负责人:
- 金额:$ 3.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-05 至 2017-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAfrican AmericanAlcoholsBehaviorBenefits and RisksBloodClinical TrialsConsent FormsControl GroupsDecision MakingDevelopmentEnrollmentEthicsEthnic groupExclusion CriteriaFinancial compensationHealthHealth BenefitHispanicsIllicit DrugsIncentivesIndividualInterviewInvestigationInvestigational DrugsKnowledgeLeadLengthLightLogisticsLongitudinal StudiesMedical ResearchMinorityMinority GroupsNot Hispanic or LatinoParticipantPatternPerceptionPharmaceutical PreparationsPhasePhase I Clinical TrialsPhase III Clinical TrialsPopulationProceduresPsychotropic DrugsPublic HealthQualifyingRaceRecommendationRecruitment ActivityResearchResearch DesignResearch PersonnelRiskStructureTherapeutic Clinical TrialTimeTobaccoUnited States National Institutes of HealthWeightbasedesigndiarieshealthy volunteerimprovedinsightmemberphase 1 studyprospectiveracial and ethnicrisk perceptionsafety testingself reported behaviortoolvolunteer
项目摘要
The proposed project will investigate healthy volunteers' patterns of participation in Phase I clinical trials, attending to differences based on their racial and ethnic backgrounds. It focuses on the relationship over time between healthy volunteers' perceptions of the risks and benefits of trial participation and their decision-making and behaviors surrounding enrollment in those studies. The majority of healthy volunteers in clinical trials are serial participants, meaning that they enroll repeatedly in studies, so a longitudinal study design is needed to understand their patterns of participation in clinical trial. The project is designed with four primary aims:
1. Assess how participants' perceptions of the risks and benefits of Phase I participation change overtime;
2. Examine how participants make decisions regarding their participation in clinical trials - including continuing serial participation - and assess the consistency of their choices over time;
3. Document how participants' self-reported behaviors (a) affect the validity of clinical trials and (b) increase and/or mitigate harm that could come from serial participation, including behaviors that have health benefits; and
4. Compare participants' perceptions, decisions, and behaviors across racial and ethnic groups.
This 5-year project is a prospective, longitudinal, qualitative study and includes 200 healthy volunteers (50 1st-times Phase I participants, 50 2nd-time participants, 50 3rd-5th-time participants, and 50 6th+-time participants) who will be followed for 3 years. They will participate in 5 semi-structured interviews (total of 880): at enrollment, 6 months, 1 year, 2 years, and 3 years. Participants will also maintain "clinical trial diaries" documenting their activities in Phase I studies between interviews. In each group, 10 participants will serve as controls and be interviewed only at enrollment and at three years. The control group will be used to evaluate whether the interviews and diaries have an unintended interventional effect on volunteers over the course of the study.
拟议的项目将调查健康志愿者参与第一阶段临床试验的模式,关注基于其种族和民族背景的差异。它重点关注健康志愿者对参与试验的风险和益处的看法与他们围绕这些研究的入组决策和行为之间随时间的关系。临床试验中的大多数健康志愿者都是连续参与者,这意味着他们重复参加研究,因此需要纵向研究设计来了解他们参与临床试验的模式。该项目的设计有四个主要目标:
1. 评估参与者对第一阶段参与的风险和收益的看法如何随着时间的推移而变化;
2. 检查参与者如何做出有关参与临床试验的决定(包括持续连续参与),并评估他们的选择随着时间的推移的一致性;
3. 记录参与者的自我报告行为(a)如何影响临床试验的有效性和(b)增加和/或减轻连续参与可能带来的伤害,包括对健康有益的行为;和
4. 比较不同种族和族裔群体的参与者的看法、决定和行为。
这个为期 5 年的项目是一项前瞻性、纵向、定性研究,包括 200 名健康志愿者(50 名第一次第一阶段参与者、50 名第二次参与者、50 名第三至第五次参与者和 50 名第六次以上参与者),他们将跟踪3年。他们将参加 5 次半结构化面试(总共 880 次):入学时、6 个月、1 年、2 年和 3 年。参与者还将保留“临床试验日记”,记录他们在访谈之间的第一阶段研究活动。每组 10 名参与者将作为对照组,仅在入学时和三年后接受采访。对照组将用于评估访谈和日记在研究过程中是否对志愿者产生意外的干预作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JILL A FISHER其他文献
JILL A FISHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JILL A FISHER', 18)}}的其他基金
Challenging Allergies: The Search for a Magic Bullet for Pediatric Food Allergies
挑战过敏:寻找治疗儿童食物过敏的灵丹妙药
- 批准号:
10578414 - 财政年份:2023
- 资助金额:
$ 3.85万 - 项目类别:
Exploring the Ethical Dimensions of Peanut Allergy Immunotherapy Research
探索花生过敏免疫治疗研究的伦理维度
- 批准号:
10308499 - 财政年份:2020
- 资助金额:
$ 3.85万 - 项目类别:
Factors Affecting Healthy Volunteers' Long-Term Participation in Clinical Trials
影响健康志愿者长期参与临床试验的因素
- 批准号:
8536871 - 财政年份:2012
- 资助金额:
$ 3.85万 - 项目类别:
Factors Affecting Healthy Volunteers' Long-Term Participation in Clinical Trials
影响健康志愿者长期参与临床试验的因素
- 批准号:
8370327 - 财政年份:2012
- 资助金额:
$ 3.85万 - 项目类别:
Factors Affecting Healthy Volunteers' Long-Term Participation in Clinical Trials
影响健康志愿者长期参与临床试验的因素
- 批准号:
8852136 - 财政年份:2012
- 资助金额:
$ 3.85万 - 项目类别:
Factors Affecting Healthy Volunteers' Long-Term Participation in Clinical Trials
影响健康志愿者长期参与临床试验的因素
- 批准号:
8664894 - 财政年份:2012
- 资助金额:
$ 3.85万 - 项目类别:
Phase I Clinical Trials and the Informed Consent of Healthy Subjects
I期临床试验和健康受试者的知情同意
- 批准号:
7589336 - 财政年份:2009
- 资助金额:
$ 3.85万 - 项目类别:
Phase I Clinical Trials and the Informed Consent of Healthy Subjects
I期临床试验和健康受试者的知情同意
- 批准号:
7776864 - 财政年份:2009
- 资助金额:
$ 3.85万 - 项目类别:
Informed Consent in Private Sector Mental Health Research
私营部门心理健康研究中的知情同意
- 批准号:
6742231 - 财政年份:2003
- 资助金额:
$ 3.85万 - 项目类别:
Informed Consent in Private Sector Mental Health Research
私营部门心理健康研究中的知情同意
- 批准号:
6803563 - 财政年份:2003
- 资助金额:
$ 3.85万 - 项目类别:
相似国自然基金
社会网络关系对公司现金持有决策影响——基于共御风险的作用机制研究
- 批准号:72302067
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高尿酸调控TXNIP驱动糖代谢重编程影响巨噬细胞功能
- 批准号:82370895
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
倒装芯片超声键合微界面结构演变机理与影响规律
- 批准号:52305599
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
寒地城市学区建成环境对学龄儿童心理健康的影响机制与规划干预路径研究
- 批准号:52378051
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
原位研究聚变燃料纯化用Pd-Ag合金中Ag对辐照缺陷演化行为的影响及其相互作用机制
- 批准号:12305308
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
1/2 药物开发和能力建设:UCR/CoH-CCC 合作伙伴关系
- 批准号:
10762157 - 财政年份:2023
- 资助金额:
$ 3.85万 - 项目类别:
Translational genomics in gout: From GWAS signal to mechanism
痛风的转化基因组学:从 GWAS 信号到机制
- 批准号:
10735151 - 财政年份:2023
- 资助金额:
$ 3.85万 - 项目类别:
SELENOF is a Novel Tumor Suppressor and a New Target to Overcome Racial Disparity in Breast Cancer.
SELENOF 是一种新型肿瘤抑制剂,也是克服乳腺癌种族差异的新靶点。
- 批准号:
10735662 - 财政年份:2023
- 资助金额:
$ 3.85万 - 项目类别:
Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA)
芝加哥不同高危女性人群乳腺癌替代预防研究 (CAPSBRACA)
- 批准号:
10737279 - 财政年份:2023
- 资助金额:
$ 3.85万 - 项目类别:
Simulating Ancestrally Unbiased Tumor Evolution To Interrogate Drug Resistance
模拟祖先无偏见的肿瘤进化来询问耐药性
- 批准号:
10687776 - 财政年份:2023
- 资助金额:
$ 3.85万 - 项目类别: